Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Catalyst Group International is a private international consulting and market-development firm rather than a drug developer or healthcare operating company. The company describes itself as providing consulting services across political affairs, market development, market management, mergers and acquisitions, crisis management, cybersecurity, tourism, and entrepreneurial initiatives. Its website lists life sciences among the industries it has served, but available public information indicates that this is advisory work for clients rather than an in-house biopharma pipeline. Public references also tie the company to founder and president Rami Levi and a long history of cross-border governmental, nonprofit, and commercial projects. For biotech diligence purposes, Catalyst Group International appears best classified as a general strategic consultancy with occasional life sciences exposure, not as a therapeutics, diagnostics, or healthcare products company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Catalyst Group International.